ARCHIVE
A Conversation about Intersectionality in the Psychedelic Community
A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.
Reclaiming Your Identity As A Drug User
Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”
Cartoon Dystopia: 25I-NBOMe and Why You Should Test Your LSD
Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.
Adam Strauss on Ketamine for OCD, Trip Sitters, and The Mushroom Cure Los Angeles
Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.
How should we be teaching students about drugs?
Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”
How to meditate on psychedelics with Vincent Horn of Meditate.io
Vincent Horn of Meditate.io talks about psychedelics and meditation.
For someone who hasn’t taken a psychedelic drug it can be difficult to imagine what it’s like.
Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.
Salvinorin A. Is it possible to have a truly powerful painkiller that is not addictive?
We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?
Becoming a Psychedelic Researcher: Alan Kooi Davis
Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.
How activists are fighting for full cannabis legalization in Washington, D.C.
When two men entered a party in Uneeda Nichols’ home in Washington, D.C. in August 2017 with a couple hundred dollars in cash, they were greeted as cannabis enthusiasts. No one realized they were undercover cops.
We talked with a researcher using psilocybin for cocaine addiction in Alabama
I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.
LSD Cured My Eating Disorder
As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.
We now call ‘bad trips’ ‘challenging experiences’. Here’s why that’s misguided.
Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.
Psychedelics and the Full-Fluency Phenomenon
I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.
DREAMing about Drug Reform: An Interview with Arturo Lua Castillo
A candid talk with Arturo Lua Castillo, named Outstanding Student Organizer of 2018 by Students for Sensible Drug Policy.
Humans of the Commission on Narcotic Drugs
Meet some of the people on the front lines of global drug reform at The Commission on Narcotic Drugs in Vienna.
Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11
The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.
Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10
The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.
How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9
The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.
How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8
The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.
Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7
The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."
Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6
The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.
Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5
The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.
We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4
The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.
How has Western influence changed the traditional use of iboga in Gabon? | Part 3
The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.
ARCHIVE
A Conversation about Intersectionality in the Psychedelic Community
A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.
Reclaiming Your Identity As A Drug User
Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”
Cartoon Dystopia: 25I-NBOMe and Why You Should Test Your LSD
Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.
Adam Strauss on Ketamine for OCD, Trip Sitters, and The Mushroom Cure Los Angeles
Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.
How should we be teaching students about drugs?
Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”
How to meditate on psychedelics with Vincent Horn of Meditate.io
Vincent Horn of Meditate.io talks about psychedelics and meditation.
For someone who hasn’t taken a psychedelic drug it can be difficult to imagine what it’s like.
Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.
Salvinorin A. Is it possible to have a truly powerful painkiller that is not addictive?
We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?
Becoming a Psychedelic Researcher: Alan Kooi Davis
Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.
How activists are fighting for full cannabis legalization in Washington, D.C.
When two men entered a party in Uneeda Nichols’ home in Washington, D.C. in August 2017 with a couple hundred dollars in cash, they were greeted as cannabis enthusiasts. No one realized they were undercover cops.
We talked with a researcher using psilocybin for cocaine addiction in Alabama
I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.
LSD Cured My Eating Disorder
As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.
We now call ‘bad trips’ ‘challenging experiences’. Here’s why that’s misguided.
Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.
Psychedelics and the Full-Fluency Phenomenon
I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.
DREAMing about Drug Reform: An Interview with Arturo Lua Castillo
A candid talk with Arturo Lua Castillo, named Outstanding Student Organizer of 2018 by Students for Sensible Drug Policy.
Humans of the Commission on Narcotic Drugs
Meet some of the people on the front lines of global drug reform at The Commission on Narcotic Drugs in Vienna.
Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11
The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.
Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10
The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.
How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9
The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.
How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8
The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.
Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7
The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."
Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6
The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.
Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5
The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.
We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4
The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.
How has Western influence changed the traditional use of iboga in Gabon? | Part 3
The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.